ICU Medical, Inc. (ICUI)
USD 154.07
(-1.97%)
USD 154.07
(-1.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 166.2 Million | -62.12 Million | 267.53 Million | 222.75 Million | 101.91 Million | 160.21 Million |
| Net Income | -29.65 Million | -74.28 Million | 103.13 Million | 86.87 Million | 101.03 Million | 28.79 Million |
| Depreciation & Amortization | 250.68 Million | 235.15 Million | 89.69 Million | 94.84 Million | 85.21 Million | 74.73 Million |
| Deferred income taxes | 25.74 Million | - | 2.82 Million | 3.77 Million | 27.62 Million | 20.27 Million |
| Stock-based compensation | 40.56 Million | 36.02 Million | 27.34 Million | 23.95 Million | 21.91 Million | 24.24 Million |
| Change in working capital | -135.6 Million | -303.72 Million | 15.03 Million | -16.96 Million | -111.63 Million | -25.4 Million |
| Other non-cash items | 14.46 Million | 44.71 Million | 29.49 Million | 30.27 Million | -22.22 Million | 37.58 Million |
| Investing Cash Flow | -87.94 Million | -1.9 Billion | -90.68 Million | -98.13 Million | -166.88 Million | -103.37 Million |
| Investments in PPE | -93.67 Million | -99.32 Million | -81.16 Million | -100.39 Million | -106.04 Million | -100.77 Million |
| Acquisitions | 1.5 Million | -1.84 Billion | -14.45 Million | -8.38 Million | -76.13 Million | -1.3 Million |
| Investment purchases | -1.5 Million | -3.39 Million | -13.28 Million | -32.82 Million | -26.04 Million | -30.49 Million |
| Sales/Maturities of investments | 4.22 Million | 36.43 Million | 18 Million | 28.9 Million | 41.29 Million | 15.44 Million |
| Other Investing Activities | 1.5 Million | 989 Thousand | 218 Thousand | 14.56 Million | 33 Thousand | 13.76 Million |
| Financing Cash Flow | -35.97 Million | 1.63 Billion | -16.87 Million | -40 Thousand | -10.9 Million | 8.02 Million |
| Debt repayment | -30.65 Million | -23.05 Million | -607 Thousand | -150.35 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -9.35 Million | -10.88 Million | -8.33 Million | -12.87 Million | -18.63 Million | -6.25 Million |
| Common Stock Issuance | 4.02 Million | 8.78 Million | 9.37 Million | 13.19 Million | 7.73 Million | 14.27 Million |
| Other Financing Activities | 4.02 Million | 1.67 Billion | -16.26 Million | 150.31 Million | -10.9 Million | 14.27 Million |
| Accounts receivables | 48.63 Million | -19.15 Million | 13.75 Million | 78.04 Million | -23.68 Million | -76.74 Million |
| Accounts payables | -68.3 Million | 37.47 Million | 2.34 Million | -46.41 Million | -2.69 Million | 23.27 Million |
| Inventory | -6.07 Million | -201.09 Million | 20.81 Million | 19.19 Million | -24.99 Million | -21.77 Million |
| Other working capital | -109.85 Million | -120.95 Million | -21.87 Million | -67.79 Million | -60.25 Million | 49.83 Million |
| Cash at beginning of period | 208.78 Million | 552.82 Million | 396.09 Million | 268.67 Million | 344.78 Million | 290.07 Million |
| Cash at end of period | 254.22 Million | 208.78 Million | 552.82 Million | 396.09 Million | 268.67 Million | 344.78 Million |
| Capital Expenditure | -93.67 Million | -99.32 Million | -81.16 Million | -100.39 Million | -106.04 Million | -100.77 Million |
| Effect of forex changes on cash | 3.16 Million | -9.47 Million | -3.25 Million | 2.85 Million | -234 Thousand | -10.15 Million |
| Net cash flow / Change in cash | 45.43 Million | -344.04 Million | 156.73 Million | 127.42 Million | -76.11 Million | 54.7 Million |
| Free Cash Flow | 72.53 Million | -161.45 Million | 186.36 Million | 122.36 Million | -4.12 Million | 59.43 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.4 Million | -39.47 Million | -29.65 Million | -17.14 Million | 7.23 Million | -9.93 Million |
| Depreciation & Amortization | 55.31 Million | 55.52 Million | 250.68 Million | 57.15 Million | 58.37 Million | 57.5 Million |
| Deferred income taxes | 1.87 Million | - | 25.74 Million | -19.53 Million | -12.6 Million | 3.5 Million |
| Stock-based compensation | 10.99 Million | 11.59 Million | 40.56 Million | 10.68 Million | 10.94 Million | 9.77 Million |
| Change in working capital | 24.48 Million | 4.09 Million | -135.6 Million | 14.05 Million | -37.71 Million | -82.11 Million |
| Other non-cash items | 130.39 Million | 103.24 Million | 14.46 Million | 46.04 Million | 8.92 Million | 19.79 Million |
| Investing Cash Flow | -21.69 Million | -17.86 Million | -87.94 Million | -30.65 Million | -24.5 Million | -17.6 Million |
| Investments in PPE | -21.87 Million | -18.86 Million | -93.67 Million | -31.97 Million | -24.55 Million | -20.4 Million |
| Acquisitions | 185 Thousand | 507 Thousand | 1.5 Million | 20 Thousand | 50 Thousand | 1.37 Million |
| Investment purchases | - | - | -1.5 Million | 1.43 Million | - | -1.37 Million |
| Sales/Maturities of investments | - | 500 Thousand | 4.22 Million | 1.3 Million | - | 1.42 Million |
| Other Investing Activities | 185 Thousand | 507 Thousand | 1.5 Million | -1.43 Million | 50 Thousand | 1.37 Million |
| Financing Cash Flow | -10.38 Million | -26.84 Million | -35.97 Million | -7.84 Million | -6.39 Million | -5.89 Million |
| Debt repayment | -13.02 Million | -12.99 Million | -30.65 Million | -7.72 Million | -7.68 Million | -7.66 Million |
| Dividends payments | - | - | - | -11.47 Million | - | - |
| Common Stock Repurchased | -285 Thousand | -11.4 Million | -9.35 Million | -129 Thousand | -503 Thousand | -293 Thousand |
| Common Stock Issuance | 2.92 Million | 150 Thousand | 4.02 Million | -4.02 Million | 1.78 Million | 2.06 Million |
| Other Financing Activities | -285 Thousand | -14 Million | 4.02 Million | 9.22 Million | 1.78 Million | 2.06 Million |
| Accounts receivables | -7.25 Million | 13.96 Million | 48.63 Million | 5.54 Million | -3.71 Million | -35.23 Million |
| Accounts payables | 4.11 Million | 5.31 Million | -68.3 Million | -3.25 Million | -18.18 Million | -19.33 Million |
| Inventory | 6.93 Million | 14.16 Million | -6.07 Million | 60.58 Million | 9.37 Million | -26.67 Million |
| Other working capital | 20.68 Million | -29.34 Million | -109.85 Million | -48.82 Million | -25.19 Million | -873 Thousand |
| Cash at beginning of period | 251.42 Million | 254.22 Million | 208.78 Million | 197.19 Million | 195.88 Million | 220.94 Million |
| Cash at end of period | 302.64 Million | 251.42 Million | 254.22 Million | 254.22 Million | 197.19 Million | 195.88 Million |
| Capital Expenditure | -21.87 Million | -18.86 Million | -93.67 Million | -31.97 Million | -24.55 Million | -20.4 Million |
| Effect of forex changes on cash | 1.34 Million | -3.88 Million | 3.16 Million | 4.26 Million | -2.95 Million | -83 Thousand |
| Net cash flow / Change in cash | 51.22 Million | -2.79 Million | 45.43 Million | 57.03 Million | 1.3 Million | -25.06 Million |
| Free Cash Flow | 60.07 Million | 26.92 Million | 72.53 Million | 59.29 Million | 10.6 Million | -21.87 Million |
7276
8218
4516
7999
SIS
BIRD